Generic Drug Labeling

Witnesses testified at a hearing on the Food and Drug Administration’s FDA’s proposal to have generic drug makers update their… read more

Witnesses testified at a hearing on the Food and Drug Administration’s FDA’s proposal to have generic drug makers update their safety labels as soon as the information becomes available. At the time of this hearing, generic brands could not update labels unless the original developer did so. Some lawmakers expressed concern that the rule change could create contradictory labels for the same medicine. FDA official in charge of drug evaluation and research Janet Woodcock testified the first panel. In a separate panel, the subcommittee also heard from the president of the Generic Pharmaceutical Association. close

*The transcript for this program was compiled from uncorrected Closed Captioning.

People in this video

More People

Hosting Organization

More information about

Generic Drug Labeling

270 Views
Program ID:
318627-1
Category:
House Committee
Format:
House Committee
Location:
Washington, District of Columbia, United States
First Aired:
Apr 1, 2014
Last Aired:
Apr 16, 2014

Airing Details

  • Apr 01, 2014 | 3:00pm EDT | C-SPAN.org
  • Apr 04, 2014 | 9:54pm EDT | C-SPAN 3
  • Apr 05, 2014 | 3:54am EDT | C-SPAN 3
  • Apr 16, 2014 | 11:34am EDT | C-SPAN 3
Purchase a DVD or Download

Generic Drug Labeling

  • DVD
    Length:
    02:12:36
    Price:
    $29.95
    Add to Cart
  • MP4 video - Standard
    Length:
    02:12:36
    Price:
    $6.99
    Add to Cart
  • MP4 video - Low
    Length:
    02:12:36
    Price:
    $5.99
    Add to Cart
  • MP3 audio
    Length:
    02:12:36
    Price:
    $0.99
    Add to Cart

Clips from This Video